Advanced
search

Search results

1 – 5 of 5
View access options
Expert briefing
Publication date: 8 January 2021
Expert Briefings Powered by Oxford Analytica

FDI reached USD40bn in April-September 2020, a 13% rise compared with the corresponding period in 2019. FPI totalled nearly USD23bn in 2020, up 58% from 2019.
View access options
Expert briefing
Publication date: 27 July 2016
Expert Briefings Powered by Oxford Analytica

Outlook for a possible free trade deal between India and the United Kingdom post-Brexit.
View access options
Expert briefing
Publication date: 16 March 2016
Expert Briefings Powered by Oxford Analytica

Correlation between oil prices, equity markets and global growth.
View access options
Expert briefing
Publication date: 11 November 2020
Expert Briefings Powered by Oxford Analytica

Divided government provides scope for volatility at a perilous time for the pandemic-ravaged US economy, but markets are putting greater weight on the prospect of a vaccine…

Details

DOI: 10.1108/OXAN-DB257477

ISSN: 2633-304X

Keywords

Geographic
International
Topical
economy
bonds
capital flows
election
equities
finance
growth
health
pharmaceutical
welfare
View access options
Expert briefing
Publication date: 19 August 2019
Expert Briefings Powered by Oxford Analytica

The impact on Greece of a no-deal Brexit.

Access

Year

Content type

Refine By Country
{"C":[{"count":"3","title":"China","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22China%22"},{"count":"2","title":"Cyprus","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Cyprus%22"}],"F":[{"count":"1","title":"France","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22France%22"}],"G":[{"count":"1","title":"Germany","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Germany%22"},{"count":"1","title":"Greece","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Greece%22"}],"H":[{"count":"1","title":"Hong Kong","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Hong+Kong%22"}],"I":[{"count":"2","title":"India","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22India%22"},{"count":"1","title":"Ireland","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Ireland%22"},{"count":"1","title":"Italy","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Italy%22"}],"J":[{"count":"1","title":"Japan","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Japan%22"}],"M":[{"count":"2","title":"Mauritius","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Mauritius%22"}],"P":[{"count":"1","title":"Pakistan","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Pakistan%22"},{"count":"1","title":"Portugal","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Portugal%22"}],"S":[{"count":"2","title":"Singapore","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Singapore%22"},{"count":"1","title":"Spain","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Spain%22"},{"count":"1","title":"Sweden","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Sweden%22"}],"T":[{"count":"1","title":"Taiwan","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Taiwan%22"}],"U":[{"count":"3","title":"United Kingdom","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22United+Kingdom%22"},{"count":"3","title":"United States","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22equities%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22United+States%22"}]}
1 – 5 of 5
Manage cookies

We’re listening — tell us what you think

Join us on our journey